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Abstract Recently, we have shown that the N subunit of the
cGMP phosphodiesterase (PDE N) interacts with the retinitis
pigmentosa guanine regulator (RPGR). Here, using the two-
hybrid system, we identify a member of the Arf-like protein
family of Ras-related GTP-binding proteins, Arl3, that interacts
with PDE N. The interaction was verified by fluorescence
spectroscopy and co-immunoprecipitation. Arl3 features an
unusually low affinity for guanine nucleotides, with a KD of 24
nM for GDP and 48 WM for GTP. Fluorescence spectroscopy
shows that PDE N binds and specifically stabilizes the GTP-
bound form of Arl3 by strongly decreasing the dissociation rate
of GTP. Thus, PDE N is an effector of Arl3 and could provide a
novel nucleotide exchange mechanism by which PDE N stabilizes
Arl3 in its active GTP-bound form.
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1. Introduction
Retinitis pigmentosa (RP) designates a heterogeneous group
of hereditary retinal dystrophies characterized by impaired
dark adaptation, progressive visual ¢eld defects and severe
reduction in visual acuity. X-linked RP (xlRP) is the most
severe form of RP. The most common form of xlRP is RP
type 3 (RP3) which a¡ects about 70% of xlRP patients and is
caused by mutations in the RP guanine regulator gene
(RPGR). The full length RPGR gene encodes a 90 kDa pro-
tein. However, it appears to be spliced in a tissue speci¢c
manner and in human and bovine retina, a 52 kDa version
is most abundant (A. Wright, unpublished observations). The
52 kDa RPGR protein contains a domain which is homolo-
gous to the regulator of chromosome condensation (RCC1),
the guanine nucleotide exchange factor of Ran [1,2]. Mouse
RPGR has been localized to the Golgi apparatus by immuno-
£uorescence studies, indicating a possible role in vesicular
transport [3]. Recently, we have identi¢ed the N subunit of
the rod cyclic GMP phosphodiesterase (PDE N) to interact
with the RCC1-like domain (RLD) of RPGR. Mutants of
RPGR found in RP3 patients are unable to interact with
PDE N [4].
PDE N was isolated as the fourth subunit of bovine rod
PDE (PDE6) [5]. PDE6 is the e¡ector for the trimeric G
protein transducin after its activation by light sensitive rho-
dopsin molecules. PDE N was originally shown to bind to the
prenylated C-terminus of PDE K,L, which resulted in a trans-
location of the PDE6 holoenzyme from a membrane to a
cytoplasmic fraction [6]. Furthermore, PDE N has previously
been shown to solubilize membrane-bound Rab13 to the cy-
toplasm [7]. Together, this suggested a possible function for
PDE N similar to the function of GDP dissociation inhibitors
(GDIs), which bind to the prenylated proteins to extract them
from cellular membranes. To further elucidate the function of
PDE N, we subjected PDE N to a two-hybrid screen. We iden-
ti¢ed an Arf-like protein, Arl3, which binds PDE N in its
GTP-bound but not GDP-bound conformation, suggesting a
possible role for PDE N as an e¡ector for Arl3.
2. Material and methods
2.1. Plasmids and strains
PDE N was cloned as a BamHI fragment into the two-hybrid vector
pBTM116 and as a BamHI/EcoRI fragment into pVP16, pET28a and
Flag-pcDNA3. Restriction sites were generated by PCR using appro-
priate primers. Arl3, Arl3T31N and Arl3Q71L (mutations were gen-
erated according to Picard et al. [8]) were cloned as a EcoRI/BamHI
fragment into pBTM116, as a NcoI/HindIII fragment into pET21d
and as a KpnI/BamHI fragment into pcDNA3. All clonings and mu-
tations were veri¢ed by cycle sequencing. Saccharomyces cerevisiae
reporter strain L40: MATa, his3v200, trp1-901, leu2-3,112, ade2,
LYS: :(lexAop)4-HIS3, URA3: :(lexAop)8-lacZ, GAL4, gal80. E. coli
strains for protein expression: BL21 (DE3) and B834 (DE3) pLysS
(Novagen).
2.2. Two-hybrid screening
We used murine PDE N in pBTM116 as bait plasmid of the lexA-
based two-hybrid system (containing the L40 reporter strain, the
pBTM116 and pVP16 vectors and the murine cDNA library fused
to pVP16), kindly provided by Stan Hollenberg (Vollum Institute,
Portland, OR, USA). The yeast reporter strain L40 was transformed
with the PDE N construct as described [9]. We screened 5U107 clones
containing a size-selected mouse cDNA library of 9.5^10.5 day em-
bryos cloned in pVP16. After 4 days at 30‡C, we obtained 18 Arl3
clones on medium selecting for protein-protein interaction (i.e.
THULLy medium which lacks tryptophan, histidine, uracil, leucine
and lysine; 25 mM 3-aminotriazole was also added to compensate for
basal promotor activity).
2.3. Two-hybrid interaction assay
The reporter strain L40 was transformed with the appropriate con-
structs. The resulting transformants were grown for 4 days on me-
dium selecting either for the presence of both plasmids (i.e. UTL
medium lacking uracil, tryptophan and leucine) or for protein-protein
interaction (i.e. THULLy medium)
2.4. Protein expression
5 l LB medium containing ampicillin was inoculated with an over-
night culture of Arl3-pET21d-BL21 (DE3). Overnight expression at
30‡C was induced at an OD600 of 0.7 with 100 WM IPTG. Arl3 protein
was isolated from 100 000Ug supernatant in 100 mM Tris-HCl, pH
9.0, 2 mM MgCl2 with SourceQ chromatography (Pharmacia). Am-
monium sulfate precipitation and S-75 Superdex chromatography in
50 mM Tris-HCl, pH 7.5, 2 mM MgCl2 yielded pure and nucleotide-
free protein. PDE N expression at 28‡C in the pET28a-B834 (DE3)-
pLysS system was induced with 300 WM IPTG at an OD600 of 0.6.
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Cells were harvested after 6 h and the 100 000Ug supernatant in 50
mM Tris-HCl, pH 7.5, 150 mM NaCl was applied onto a Ni2 NTA
column (Qiagen). After imidazole elution, PDE N was stabilized in
bu¡er with 10% glycerol.
2.5. Transfection and immunoprecipitation
Human 293 kidney cells [10] were cultured in MEM with Glutamax
(Gibco) and 10% fetal calf serum and transfected using the calcium-
chloride method. To assay protein expression, cells were transfected
either with wild-type (WT) Arl3, Arl3T31N, Arl3Q71L in pcDNA3 or
with Flag-tagged PDE N in pcDNA3, respectively. After 48 h, cells
were harvested and protein expression was detected by Western blot-
ting using either a polyclonal anti-ARL3 antibody from rabbit (pro-
duced by immunization of two rabbits with native Arl3 and subse-
quent protein G-Sepharose puri¢cation of the sera) or a mouse
monoclonal anti-Flag antibody (M5, Sigma). For co-immunoprecipi-
tation of the PDE N-Arl3 complex, cells were co-transfected with the
appropriate Arl3 construct and PDE N. After 48 h, cells were lysed by
soni¢cation in lysis bu¡er (30 mM Tris-HCl, pH 7.5, 2 mM EDTA,
100 mM NaCl, 5 mM MgCl2, 0.5% NP-40, 2.5% glycerol and pro-
tease inhibitor (Boehringer complete)). The lysate was successively
incubated with anti-Flag antibody and protein G-Sepharose (Pharma-
cia) for 1 h. After washing the protein G-Sepharose twice with lysis
bu¡er, protein was detected by Western blotting using anti-ARL3,
anti-Flag, anti-rabbit and anti-mouse horseradish peroxidase (HRP)
antibody (HRP conjugates from Amersham).
2.6. Fluorescence measurements
All measurements were recorded with a Fluoromax-2 spectropho-
tometer (Spex Industries, Edison, UK) using N-methylanthranil acid-
labelled guanine nucleotide (mant guanine nucleotide). Mant £uores-
cence was excited at 350 nm. All measurements were performed in 50
mM KPO4, pH 7.4, 2 mM MgCl2 at 30‡C. The nucleotide concen-
tration was determined by reverse phase HPLC with a C18 column in
100 mM K2HPO4/KH2PO4, 10 mM tetrabutylammoniumbromide
and 20% acetonitrile.
3. Results
Using PDE N as a bait in a two-hybrid screen together with
a mouse embryo cDNA library, we obtained the Arl3 gene as
a potential candidate (accession: GenBank AF143241). The
interaction of PDE N and Arl3 in the two-hybrid system was
deemed speci¢c since Arl3 also interacted with PDE N when
present on the bait plasmid but did not interact with lamin.
Furthermore, PDE N did not interact with Ran, another small
GTP-binding protein used as a control (Fig. 1a).
Arl3 is 45% identical to Arf1 and thought to have an anal-
ogous function in intracellular transport like it was suggested
for its close relative Arl2 [11]. As the function of guanine
nucleotide-binding proteins is mainly determined by their nu-
cleotide-binding characteristics, we ¢rst determined the nu-
cleotide a⁄nity of WT-Arl3 and of two mutants, Arl3T31N
and Arl3Q71L. In analogy to Ras and other small GTP-bind-
ing proteins, the T31N mutant is assumed to be predomi-
nantly in its GDP-bound conformation [12], whereas the
Q71L mutant is predicted to be in the GTP-bound state as
this mutation inactivates GTP hydrolysis [13]. The nucleotide
Fig. 1. Interaction of Arl3 with PDE N in the two-hybrid system. a:
The plasmid combinations used for yeast transformation are shown
on the left panel, the growth of the appropriate yeast clones on me-
dium selecting either for the presence of both plasmids (UTL) or
for protein-protein interaction (THULLy) is shown on the right
panel. Arl3 interacts with human and with the 98% identical murine
PDE N in both plasmid combinations. As negative controls, lamin
and the small GTPase Ran were used. b: Interaction of WT-Arl3
and its mutants T31N and Q71L with murine PDE N in the two-hy-
brid system. Arl3 and Arl3Q71L grew on THULLy medium as indi-
cator for protein-protein interaction whereas Arl3T31N did not in-
teract with PDE N.
Fig. 2. a: Expression of WT-Arl3 and its mutants Arl3T31N and
Q71L in transfected 293 cells. Human kidney 293 cells were trans-
fected with Arl3 in pcDNA3 or its mutants, respectively. 48 h after
transfection, the cell lysates were prepared for Western blotting.
Proteins were detected by rabbit anti-ARL3 antibody and anti-rab-
bit HRP-conjugated antibody. The right lane (C) contains lysate
from untransfected cells as a control. b: Arl3Q71L binds speci¢cally
to PDE N in transfected 293 kidney cells. Flag-tagged PDE N was
immunoprecipitated from 293 cells transfected with Flag-PDE N-
pcDNA3 and ARL3-pcDNA3 or its mutants, respectively. Lysates
were immunoprecipitated using anti-Flag antibodies. Immunopre-
cipitates were prepared for Western blotting and PDE N and Arl3
were detected by anti-Flag or anti-ARL3 antibodies, respectively.
PDE N expression in lysates form 293 cells after 48 h (lane 1), PDE
N after immunoprecipitation (lane 2), PDE N after immunoprecipita-
tion in the presence of WT-Arl3 (lane 3), PDE N after immunopre-
cipitation in the presence of Arl3T31N (lane 4) or in the presence
of Arl3Q71L (lane 5). Only Arl3Q71L was co-immunoprecipitated
with PDE N. This indicates a GTP speci¢c Arl3-PDE N interaction
under physiological conditions. The lysate in lane 6 was treated like
in lane 5 but the antibodies were omitted to account for unspeci¢c
binding to protein G-Sepharose.
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a⁄nity was determined by £uorescence spectroscopy using
mant-labelled guanine nucleotide analogs. First, increasing
concentrations of nucleotide-free Arl3 were added to 0.2 WM
mantGDP or mantGTP. The time dependent increase of £uo-
rescence was used to determine kobs. kobs was plotted against
the Arl3 concentrations to calculate the rate constant of nu-
cleotide association (kass). Using the equilibrated solution of
protein and labelled nucleotide, the rate constant of nucleo-
tide dissociation (kdiss) was determined from the decrease of
the £uorescence signal after adding a 100-fold excess of un-
labelled nucleotide. The nucleotide a⁄nity as KD was calcu-
lated as a ratio of kdiss versus kass (Table 1). The mantGDP
a⁄nity of WT-Arl3 was determined to be 24 nM (Table 1),
which is in the range of the nucleotide a⁄nity determined for
Arf1 [14], a close relative of Arl proteins. The a⁄nity of
Arl3T31N, however, is 10-fold and the a⁄nity of Arl3Q71L
is 5-fold lower. Most signi¢cantly, the a⁄nity for mantGTP is
dramatically lower than that for mantGDP. The a⁄nity for
mantGTP of WT-Arl3 is 48 WM and that of Arl3Q71L is 35
WM, whereas the mantGTP a⁄nity of Arl3T31N was too low
to be measured accurately (Table 1). The decrease in guanine
nucleotide a⁄nity caused by the T31N mutation is also found
in other small GTP-binding proteins [12] and suggests a sim-
ilar role for the threonine in the coordination of nucleotide-
binding.
To investigate the nucleotide speci¢city of the interaction,
Table 1
Nucleotide a⁄nities (KD) of WT-Arl3, Arl3T31N and Arl3Q71L
determined by £uorescence measurements using mant-labelled nucleo-
tides
kdiss (s31) kass (s31 WM31) KD (nM)
MantGDP
WT-Arl3 0.00017 0.00704 24
T31N 0.00030 0.00116 260
Q71L 0.00011 0.00101 109
MantGTP
WT-Arl3 0.0351 0.00073 48
T31N n.d. n.d. n.d.
Q71L 0.0454 0.00129 35
n.d., not detectable.
Fig. 3. Change of £uorescence emission spectra of mantGDP (a) and mantGTP (b) upon successive addition of nucleotide-free Arl3 and PDE
N. 2.0 WM nucleotide-free Arl3 protein was added to 0.2 WM mant nucleotide which increased the mant £uorescence emission in both cases.
Subsequent addition of 0.5 WM PDE N increased the £uorescence only in the presence of mantGTP (b). Experiments using Arl3T31N (c) and
Arl3Q71L (d) in the presence of mantGTP showed that Arl3Q71l behaves similar to WT-Arl3 whereas Arl3T31N did not bind PDE N. Results
of corresponding experiments using mantGDP were similar to the result in (a).
FEBS 22561 1-9-99
M. Linari et al./FEBS Letters 458 (1999) 55^59 57
we used Arl3T31N and Arl3Q71L in the two-hybrid system.
The two-hybrid interaction assay showed (Fig. 1b) that WT-
Arl3 and Arl3Q71L both interacted with PDE N, whereas the
Arl3T31N mutant showed no growth on THULLy medium,
indicating no or a very weak interaction. This result suggested
that PDE N binds speci¢cally to Arl3-GTP. Essentially the
same result was obtained using recombinant GST-Arl3 and
PDE N in a pull-down experiment (data not shown).
Arl3 and PDE N are expressed in kidney tissue [6,15]. There-
fore, we used human 293 kidney cells to verify the Arl3-PDE N
interaction under physiological conditions. Transfecting 293
cells with pcDNA3-Arl3, pcDNA3-Arl3T31N or pcDNA3-
Arl3Q71L resulted in roughly the same expression as detected
by Western blotting using anti-ARL3 antiserum (Fig. 2a). To
show protein interaction in a co-immunoprecipitation experi-
ment, 293 cells were transfected with pcDNA3-Flag-PDE N
together with either pcDNA3-Arl3, pcDNA3-Arl3T31N or
pcDNA3-Arl3Q71L, respectively. PDE N was immunoprecipi-
tated via the anti-Flag antibody and the immunoprecipitant
was subsequently subjected to Western blotting. Using the
anti-ARL3 antiserum, only Arl3Q71L could be detected as a
co-immunoprecipitant (Fig. 2b). As ArlQ71L is the GTP-
bound and therefore the constitutively active form of Arl3,
this result further supported the idea that PDE N is an e¡ector
protein of Arl3 which is de¢ned as a protein that interacts
speci¢cally with the GTP-bound form of Arl3. This is parti-
ally in contrast to the result of the two-hybrid experiment
where both WT-Arl3 and Arl3Q71L interacted with PDE N.
It is likely that an Arl3 speci¢c GTPase activating protein
(GAP) converts WT-Arl3 to the GDP-bound form in the
mammalian cell system. In yeast cells, however, this GAP is
probably absent and thus, Arl3 remains in the GTP-bound
form during the two-hybrid experiment. The absence of WT-
Arl3 in the co-immunoprecipitation experiments indicates that
WT-Arl in 293 cells is mostly in the GDP-bound form despite
an estimated 20^30-fold higher intracellular concentration of
GTP. However, we cannot exclude the possibility that prepar-
ing the cells for the immunoprecipitation caused the conver-
sion of Arl3-GTP to Arl3-GDP.
The nucleotide speci¢city of the Arl3-PDE N interaction was
further analyzed by £uorescence spectroscopy. As observed
earlier, adding nucleotide-free Arl3 to mantGDP increased
the mant emission signal by 40%, whereas the addition to
mantGTP increased the emission signal by only 10% (Fig.
3). The subsequent addition of PDE N doubled the mantGTP
emission signal while there was no change in the mantGDP
emission signal. This clearly proved that PDE N speci¢cally
binds to Arl3 in its GTP-bound form but not to its GDP-
bound form. The same result was obtained using ARL3Q71L,
whereas Arl3T31N showed no increase of £uorescence in the
presence of mantGTP and PDE N (Fig. 3), most likely because
the nucleotide a⁄nity of ArlT31N was too low.
Since the a⁄nity of Arl3 for GTP was extremely low, we
hypothesized that the binding of PDE N would have to in-
crease the binding a⁄nity of Arl3 for GTP in order to ac-
count for the e⁄cient binding of the two proteins. To deter-
mine how PDE N e¡ects the binding a⁄nity of Arl3 for GTP,
0.4 WM mantGTP was incubated together with a 5-fold excess
of nucleotide-free Arl3 and increasing amounts of PDE N (Fig.
4). Increasing amounts of PDE N lead to an enhanced nucleo-
tide-binding of Arl3 as measured by the time dependent in-
crease in £uorescence. Here, the increase of the £uorescence
signal is caused by two independent steps, the binding of
mantGTP to Arl3 and the binding of PDE N to the Arl3-
mantGTP complex. The £uorescence reaches its maximum
close to an equimolar ratio of nucleotide and PDE N (about
0.5 WM), indicating the formation of a ternary mantGTP-
Arl3-PDE N complex with a 1:1:1 stoichiometry. In this com-
plex, mantGTP was bound so tightly to Arl3 that even a 250-
fold excess of unlabelled GDP could not replace mantGTP.
This e¡ect was not observed when a large excess of GDP was
added to mantGDP-ARL3 in the presence of PDE N. The
dissociation rate constant for mantGDP was determined to
be 1.1U1034 s31, regardless of whether PDE N was present
or not (data not shown). PDE N binding did not alter the
mantGTP association rate since the apparent rates (kobs) of
all binding reactions were nearly identical (Fig. 4). From these
observations, we conclude that PDE N increases the a⁄nity of
Arl3 for GTP by several orders of magnitude and does so by
decreasing the nucleotide dissociation rate which quali¢es
PDE N as a GTP speci¢c guanine nucleotide dissociation in-
hibitor.
4. Discussion
Proteins of the Arf-like family share sequence homology
with Arf proteins but they lack the typical cofactor activity
in cholera toxin-catalyzed ADP ribosylation of GKs and the
ability to rescue a lethal arf13/arf23 double mutant in S.
cerevisiae [16]. Arl proteins have been localized to the Golgi
apparatus and like their closest relatives, the Arf proteins,
they are assumed to function in intracellular transport [11].
We have isolated Arl3 in a two-hybrid screen using the N
subunit of the cGMP speci¢c rod phosphodiesterase as a
bait. The initial two-hybrid result was veri¢ed by co-immuno-
precipitation and £uorescence spectroscopy, which shows con-
clusively that PDE N binds and stabilizes Arl3-GTP by de-
creasing the nucleotide dissociation. Therefore, PDE N is not
Fig. 4. PDE N increases the mantGTP a⁄nity of Arl3. The increase
in mant emission was measured over time in the presence of 0.4 WM
mantGTP together with 1.0 WM PDE N or together with 2.0 WM
Arl3 (lower two curves). Next, increasing amounts of PDE N (0.05^
0.70 WM) and 2.0 WM nucleotide-free Arl3 were added to 0.4 WM
mantGTP (following upper curves). The addition of a 250-fold ex-
cess of unlabelled GDP after 3000 s (arrow) replaced the mantGTP
in the absence of PDE N, whereas the addition of PDE N stabilized
the mantGTP-Arl3 complex.
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only the ¢rst e¡ector protein for Arl3 identi¢ed but also a
GTP speci¢c GDI. The GDI e¡ect of PDE N is not unusual
for e¡ector proteins and was also observed for the e¡ector of
Ras, Raf kinase [17].
The 48 WM a⁄nity of Arl3 for GTP is comparatively low
and 2000-fold lower than for GDP. This suggests that in vivo,
Arl3 exists preferentially in the GDP-bound state despite the
fact that the intracellular GTP concentration is signi¢cantly
higher than the GDP concentration. However, the GTP sta-
bilizing e¡ect of PDE N binding to Arl3 shows that the nu-
cleotide-bound state is subject to regulation by other factors.
In speci¢cally stabilizing the GTP-bound state of Arl3, PDE N
could serve as a ‘passive’ nucleotide exchange factor whose
presence results in an activation of Arl3. GDP to GTP ex-
change initiates membrane anchoring of Arf1 [18] and subse-
quently vesicle formation. As PDE N is localized at intracel-
lular membranes [7]. This would suggest a role for Arl3 in
intracellular transport similar to Arf proteins.
PDE N was originally identi¢ed as the forth subunit of the
rod cyclic guanine nucleotide phosphodiesterase [5]. Initially,
PDE N was suggested to regulate the membrane localization of
the PDE holoenzyme [6] by binding to its prenylated subunits.
This function of PDE N was further supported by its ability to
bind to Rab13, a small GTP-binding protein which also pos-
sesses a C-terminal consensus motif for geranyl-geranylation.
However, our ¢nding that RPGR [4] and Arl3 bind PDE N in
the absence of any post-translational modi¢cations demon-
strates that PDE N binding is not prenylation dependent. Fur-
thermore, since PDE N binds to many proteins other than the
subunits of the PDE6 holoenzyme, it appears that PDE N is
not a genuine subunit of the PDE holoenzyme but merely an
associated protein.
The function of RPGR and therefore the cause of RP3 is
still unknown. The observation that the RPGR-binding pro-
tein PDE N interacts with small GTP-binding proteins of the
Rab and Arl family indirectly puts RPGR in the functional
context of vesicular tra⁄cking.
Since the N-terminal region of RPGR is homologous to
RCC1, the RLD of RPGR is likely to have a structure similar
to the L propeller of RCC1 [2]. Previously, another protein
with multiple RLDs, p532 [19], has been shown to interact
with proteins of the Rab and Arf family of small GTP-bind-
ing proteins, supporting a possible role of RPGR in intra-
cellular transport. It is interesting to note that another impor-
tant player in intracellular transport, the Rab escort protein 1
(REP1), is involved in a di¡erent form of retinal dystrophy
named choroideremia [20]. The binding of REP1 to Rab pro-
teins has a GDI e¡ect and interestingly, PDE N binding has a
similar e¡ect on Arl3. However, whereas PDE N interacts
preferentially with the GTP-bound form of Arl3, REP1 pre-
fers the GDP-bound form of Rab proteins [21]. Together,
these observations support our hypothesis that RPGR, PDE
N and Arl proteins regulate intracellular vesicle transport,
which we will test further in appropriate in vitro transport
systems.
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